Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.
Bilirubin-induced neural impairment: A special focus on myelination, age-related windows of susceptibility and associated co-morbidities.
Diagnostic problems in "clinically definite" multiple sclerosis patients with normal CSF and multiple MRI abnormalities.
Utilization of physical rehabilitation among people with multiple sclerosis.
On the role of natural killer cells in neurodegenerative diseases.
Changes of Cine Cerebrospinal Fluid Dynamics in Patients with Multiple Sclerosis Treated with Percutaneous Transluminal Angioplasty: Case-control Study.
The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort.
The Incidence and Prevalence of Thyroid Disease Do Not Differ in the Multiple Sclerosis and General Populations: A Validation Study Using Administrative Data.
Teaching NeuroImages: Neuromyelitis optica misdiagnosed as spinal cord tumor.
Elevated serum levels of lysophosphatidic acid in patients with multiple sclerosis.
Mode of action and clinical studies with fumarates in multiple sclerosis.
Neuropsychological Performance, Brain Imaging, and Driving Violations in Multiple Sclerosis.
Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0) - Development of an Outcome Instrument for Educational Interventions.
Recurrent Optic Neuritis in Children.
The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic.
Sphingosine-1-phosphate receptor inhibition prevents denervation-induced dendritic atrophy.
Bone health in patients with multiple sclerosis relapses.
[Relationship between the levels and variation of CXCL12, PDGF, CXCL14 in cerebrospinal fluid of optic neuritis and neuromyelitis optica].
Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2.
Clinical Nurse Specialist - A serious shortfall in numbers.
MObility ImproVEment with spasticity in multiple sclerosis in Europe: the MOVE 1 EU study.
Production and use of lentivirus to selectively transduce primary oligodendrocyte precursor cells for in vitro myelination assays.
Implications for multiple sclerosis in the era of the Affordable Care Act: a clinical overview.
Olfactory memory impairment in neurodegenerative diseases.

Pages